Patients attaining HbA1c<7.0% (53 mmol/mol) with insulin, as compared to non-attainers, were characterized by a slightly lower baseline HbA1c (8.6% (IQR, 7.7, 9.7) (70 mmol/mol (IQR, 61, 83)) vs. 9.1% (IQR, 8.1, 10.3) (76 mmol/mol (IQR, 65, 89)) and were more likely to have ≥1 vascular complication, but had about the same age, used about the same amount of NIADs and had only a slightly longer diabetes duration (Table 2). Here, INS is linked to diabetes mellitus.